FreeS Fund China-US Venture Forum Session 2 is still open for registration; FreeS Fund receives multiple recognitions from Langchao New Consumption, Joy Capital, and Qiming Technology & New Voice Innovation Service

峰瑞资本峰瑞资本·April 1, 2021

Do what's right, not what's easy.

"Frees Fund" will share updates about FreeS Fund on an irregular basis — including events, job openings, partnership opportunities, and more. We look forward to your participation as we work together on things that are meaningful and interesting, and witness innovation and the extraordinary in business.

This issue at a glance:

  • April 11, 10:00–11:30 AM: The second session of the FreeS Fund China-US Venture Capital Forum, "Seizing New Opportunities in China's Era" — "What's It Like to Do Venture Capital in China?" — will go live.
  • FreeS Fund received multiple recognitions from Langchao New Consumption, Haoyue Capital, and Qiming Technology & New Voice Innovation Services.
  • FreeS Fund is hiring investors in Beijing, Shanghai, and Shenzhen, covering biotech, deep tech, and consumer/TMT. Feel free to send your resume directly to hr@freesvc.com at any time.

One

Upcoming Events

The second live session of the 2021 FreeS Fund China-US Venture Capital Forum series "Seizing New Opportunities in China's Era" — "What's It Like to Do Venture Capital in China?" — will go live at 10:00 AM on April 11. FreeS Fund Executive Director Rui Ma and Vice President Pengqiu Liu will share their experiences investing in China, along with industry observations on biotech, deep tech, and other sectors.

If you're interested in joining the Zoom webinar, or registering for our offline event "FreeS Fund Open Day" on May 9, please scan the QR code below.

Scan to register 👆

We are looking for investors in biotech, deep tech, and consumer/TMT in Beijing, Shanghai, and Shenzhen. If you're interested in joining, we especially encourage you to sign up for our offline Open Day. How to participate: scan the QR code above. Of course, feel free to send your resume directly to hr@freesvc.com at any time.

Two

Recent Recognitions

FreeS Fund named to Langchao New Consumption's "New Wave · Top 20 Chinese New Brand Investment Institutions 2020"; FreeS Fund founding partner Feng Li selected for "New Wave · Top 10 Chinese Consumer Investors 2020"

In March, Langchao New Consumption evaluated investment institutions across multiple dimensions including portfolio valuation, follow-on round rate, project growth, and level of involvement, ultimately producing the "New Wave · Top 20 Chinese New Brand Investment Institutions 2020" list, on which FreeS Fund was included.

In addition to the institutional list, the Langchao New Consumption team — drawing on extensive in-depth interviews with top consumer investors, recommendations and submissions from dozens of leading funds (including IPO projects and investment case outcomes from the past two years), and comprehensive feedback from industry entrepreneurs — finalized the "New Wave · Top 10 Chinese Consumer Investors 2020." FreeS Fund founding partner Feng Li received this honor.

(See coverage in Langchao New Consumption: "The Unsung Heroes of the New Wave: Top 20 Chinese New Brand Investment Institutions 2020 Released" and "Top 10 Chinese Consumer Investors 2020: The Power of New-Era Bole")

FreeS Fund wins "Healthcare Early-Stage Investment Institution of the Year"; FreeS Fund founding partner Feng Li named "Healthcare Investor of the Year"; FreeS Fund Executive Director Rui Ma named "40 Under 40 · Healthcare Investor of the Year"

On March 26, the 5th Healthcare Investment Excellence Awards hosted by Haoyue Capital, a healthcare-focused investment bank, were officially announced. As a professional healthcare ranking compiled from a third-party perspective, the Excellence Awards have been published for five consecutive years, witnessing the rise of Chinese innovation and the compelling story of global capital doubling down on China. Outstanding healthcare investment institutions on the list have become accelerators and long-term partners for innovative companies, with many award-winning companies successfully going public.

FreeS Fund won "Healthcare Early-Stage Investment Institution of the Year"; FreeS Fund founding partner Feng Li was named "Healthcare Investor of the Year"; and FreeS Fund Executive Director Rui Ma was named "40 Under 40 · Healthcare Investor of the Year."

(See coverage in New Voice Innovation Services: "Celebrating Innovation | 5th Healthcare Investment Excellence Awards 2021 Announced")

FreeS Fund named by Qiming Technology & New Voice Innovation Services to "Top 30 Comprehensive Early-Stage Investment Institutions 2020" and "Top 30 Most Active Early-Stage Investment Institutions 2020"; FreeS Fund founding partner Feng Li named to "Top 100 Best Investors 2020"

On March 5, Qiming Technology & New Voice Innovation Services released five categories of rankings: annual active institutions, emerging institutions, comprehensive institutions, sector-specific institutions, and Top 100 Investors.

This annual ranking took four months to compile, collecting data from early-stage investment institutions, VC firms, and financial advisory firms through self-registration, desktop research, surveys, group visits, and phone interviews. Adhering to data as the primary principle, the rankings evaluated performance across the "raise-invest-manage-exit" cycle.

FreeS Fund was named to both "Top 30 Comprehensive Early-Stage Investment Institutions 2020" and "Top 30 Most Active Early-Stage Investment Institutions 2020," while FreeS Fund founding partner Feng Li was named to "Top 100 Best Investors 2020."

(See coverage in New Voice Innovation Services: "2020 Annual China Investment Institutions & Financial Advisor Rankings Officially Released")

Three

Current Openings

Who We Are

  • Early-stage investing as our engine, betting on rising innovative forces

Five years since its founding, FreeS has grown into a full-chain fund management company driven by early-stage investing, with active deployment in growth and late stages.

Our key investment areas include consumer upgrading, deep tech, and biotech. Portfolio companies include Three Squirrels (SZSE listed), 360 Finance (Nasdaq listed), Uber Global (NYSE listed), Unity (NYSE listed), Qingtao Development, Huasheng Haoche, Saturnbird Coffee, Yifei Automation, CoreXVision, Onion Academy, Qingqing Education, Nuoxin Chuanglian, Singleron, XtalPi, Coyote, Shangyue, 2:10 Animation, Chicecream, and Paperclip, among other innovative enterprises.

  • Championing first-principles thinking, research-driven approach

We encourage thinking and sharing, demand deeper industry research than others, and make investment decisions based on calm analysis and independent judgment.

Over the past few years, the FreeS investment team has published dozens of in-depth industry research reports totaling hundreds of thousands of words, sharing our thinking on cross-border e-commerce, virtual idols, manufacturing, biotech, education, finance, cosmetics, coffee, low-ABV alcohol, colored contact lenses, jewelry and accessories, and more.

  • Young people get ample room to grow — your thinking and voice will be heard

Our team culture has no rigid hierarchy. Young people are an important part of our investment committee and participate in investment decisions. Full-time interns can attend weekly project meetings and get frontline VC exposure.

We encourage young people to express their views and ensure their voices matter. We believe that even when young, if you're smart, curious, hardworking, and diligent, you always have perspectives on things and the right to state your attitudes and opinions.

Who We're Looking For

Biotech Investor (VP or above, based in Beijing, Shanghai, or Shenzhen)

Job Description

  • Think independently, be research-driven, continuously follow and analyze the biotech industry landscape and ecosystem, analyze business models and market conditions, and form independent investment views;
  • Conduct in-depth due diligence on companies' businesses and details to provide solid research support for investment decisions;
  • Identify outstanding early and growth-stage investment opportunities in biotech, with strong ability to source potential deals and follow through on investment progress;
  • Capable of producing industry insights and contributing to other team functions.

The Successful Applicant

  • 5+ years of experience at top-tier global biopharma companies in R&D, BD, or strategy;
  • Deep understanding of the biopharma industry with ample industry resources, capable of independently leading early and growth-stage biopharma investments;
  • Institutional biotech investors preferred; overseas Ivy League PhD or domestic first-tier university biopharma-related PhD preferred;
  • Embraces a culture of knowledge sharing and learning;
  • Smart, upright, responsible, diligent, proactive, kind, and sincere.

Tech Investor (VP or above, based in Beijing, Shanghai, or Shenzhen)

Job Description

  • Think independently, be research-driven, continuously follow and analyze semiconductors, chip sensors, robotics, industrial intelligence, hardware products, and other sectors, analyze business models and market conditions, and form independent investment views;
  • Conduct in-depth due diligence on companies' businesses and details to provide solid research support for investment decisions;
  • Identify outstanding early and growth-stage investment opportunities in hard tech, with strong ability to source potential deals and follow through on investment progress;
  • Capable of producing industry insights and contributing to other team functions.

The Successful Applicant

  • 5+ years of R&D and manufacturing experience in semiconductors, chip sensors, robotics, or related industries domestically or internationally;
  • Unique insights into the semiconductor industry and China's macroeconomy, with ample industry resources, capable of leading early and growth-stage hard tech investments;
  • Experience at leading smartphone, automotive, autonomous driving, hardware product, or IoT companies; overseas Ivy League PhD or domestic first-tier university electronics and computer science-related PhD preferred;
  • Embraces a culture of knowledge sharing and learning;
  • Smart, upright, responsible, diligent, proactive, kind, and sincere.

Consumer Investor (VP or above, based in Beijing, Shanghai, or Shenzhen)

Job Description

  • Think independently, be research-driven, continuously follow and analyze new brands, new consumption, ACGN, social, and other directions, analyze business models and market conditions, and form independent investment views;
  • Conduct in-depth due diligence on companies' businesses and details to provide solid research support for investment decisions;
  • Identify outstanding early and growth-stage investment opportunities in consumer, with strong ability to source potential deals and follow through on investment progress;
  • Capable of producing industry insights and contributing to other team functions.

The Successful Applicant

  • 5+ years of experience at leading domestic or international consumer goods, social, content, or entertainment companies in product, operations, or strategy;
  • Sensitive insight and independent views on China's macroeconomy, with extensive industry resources, capable of leading early and growth-stage consumer investments;
  • Overseas Ivy League MBA or domestic first-tier university business, economics, management, or communications master's preferred;
  • Embraces a culture of knowledge sharing and learning;
  • Smart, upright, responsible, diligent, proactive, kind, and sincere.

Please send resumes to hr@freesvc.com

*Email subject line: Application for "Biotech / Tech / Consumer Investor" – "Location"

Industry Research Intern (Based in Beijing, with return offer)

Job Description

  • Assist consumer, entertainment, education, tech, and healthcare teams with foundational industry research on domestic and international listed companies to inform decision-making;
  • Assist with investment due diligence, competitive analysis, and other tasks;
  • Daily brainstorming and thinking sessions with "Uncle Feng" and sector teams (this perk is exceptionally appealing)

The Successful Applicant

  • Compensation: 180 RMB/day, breakfast bread and milk provided, all-day fruit, Coke, coffee, and endless snacks (from portfolio company Three Squirrels)
  • Graduates of leading domestic or international universities, any major. As a research-driven VC, experience at top-tier VC/consulting/strategy/FA is a plus but not required. We value quick learning, curiosity, sensitivity, reliability, follow-through, and organization :)
  • Return offer available, 4+ days per week in office, minimum 3-month internship.

Please send resumes to hr@freesvc.com

*Email subject line: Application for "Investment Intern – Name – University – Major"

Application deadline: April 30, 2021